DYN — Dyne Therapeutics, Inc. stock price, charts and financials

QT53Dyne Therapeutics, Inc.

Dyne Therapeutics, Inc. (NASDAQ: DYN) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
17.11
-0.95-5.26%
OverviewShort InterestFilings
DYNQT53Dyne Therapeutics, Inc.·NASDAQ
17.11-5.26%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Sep 08, 20264Statement of changes in beneficial ownership
Sep 08, 20264Statement of changes in beneficial ownership
Sep 08, 20264Statement of changes in beneficial ownership
Aug 17, 20264Statement of changes in beneficial ownership
Aug 17, 20264Statement of changes in beneficial ownership
Aug 17, 20264Statement of changes in beneficial ownership
Aug 17, 20264Statement of changes in beneficial ownership
Aug 17, 20264Statement of changes in beneficial ownership
Aug 13, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 13, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 06, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jul 29, 20264Statement of changes in beneficial ownership
Jul 29, 20268-KCurrent report
Jul 29, 202610-QQuarterly report
Jul 28, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jul 22, 20268-KCurrent report
Jul 22, 2026424B5Prospectus
Jul 21, 2026424B5Prospectus
Jul 20, 20268-KCurrent report
Jul 08, 20264Statement of changes in beneficial ownership
Jun 30, 20264Statement of changes in beneficial ownership
Jun 26, 20264Statement of changes in beneficial ownership
Jun 26, 20264Statement of changes in beneficial ownership
Jun 24, 20264Statement of changes in beneficial ownership
Jun 23, 20263Initial statement of beneficial ownership
#1 / 25 of 475
Page
▼
/ 19